These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 32615872)

  • 1. The application of novel field measurement and field evaluation protocols for assessing health care workers' exposure risk to antineoplastic drugs.
    Astrakianakis G; Jeronimo M; Griffiths A; Colombo M; Kramer D; Demers PA; Hon CY
    J Occup Environ Hyg; 2020 Sep; 17(9):373-382. PubMed ID: 32615872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatial and Temporal Variability in Antineoplastic Drug Surface Contamination in Cancer Care Centers in Alberta and Minnesota.
    Jeronimo M; Arnold S; Astrakianakis G; Lyden G; Stewart Q; Petersen A; Chambers C; Malard Johnson D; Zimdars E; Kaup H; Davies HW
    Ann Work Expo Health; 2021 Aug; 65(7):760-774. PubMed ID: 33889938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wipe Sampling Method and Evaluation of Environmental Variables for Assessing Surface Contamination of 10 Antineoplastic Drugs by Liquid Chromatography/Tandem Mass Spectrometry.
    Colombo M; Jeronimo M; Astrakianakis G; Apte C; Hon CY
    Ann Work Expo Health; 2017 Oct; 61(8):1003-1014. PubMed ID: 29028255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antineoplastic drug contamination on the hands of employees working throughout the hospital medication system.
    Hon CY; Teschke K; Demers PA; Venners S
    Ann Occup Hyg; 2014 Jul; 58(6):761-70. PubMed ID: 24644303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilot assessment of the antineoplastic drug contamination levels in British Columbian hospitals pre- and post-cleaning.
    Chu WC; Hon CY; Danyluk Q; Chua PP; Astrakianakis G
    J Oncol Pharm Pract; 2012 Mar; 18(1):46-51. PubMed ID: 21737485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A quantitative LC-MS method to determine surface contamination of antineoplastic drugs by wipe sampling.
    Kåredal M; Jönsson R; Wetterling M; Björk B; Hedmer M
    J Occup Environ Hyg; 2022 Jan; 19(1):50-66. PubMed ID: 34723774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hygienic guidance values for wipe sampling of antineoplastic drugs in Swedish hospitals.
    Hedmer M; Wohlfart G
    J Environ Monit; 2012 Jul; 14(7):1968-75. PubMed ID: 22692549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application and assessment of a regular environmental monitoring of the antineoplastic drug contamination level in pharmacies - the MEWIP project.
    Kiffmeyer TK; Tuerk J; Hahn M; Stuetzer H; Hadtstein C; Heinemann A; Eickmann U
    Ann Occup Hyg; 2013 May; 57(4):444-55. PubMed ID: 23125441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sampling and mass spectrometric analytical methods for five antineoplastic drugs in the healthcare environment.
    Pretty JR; Connor TH; Spasojevic I; Kurtz KS; McLaurin JL; B'Hymer C; Debord DG
    J Oncol Pharm Pract; 2012 Mar; 18(1):23-36. PubMed ID: 21183556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of long-term data on surface contamination by antineoplastic drugs in pharmacies.
    Quartucci C; Rooney JPK; Nowak D; Rakete S
    Int Arch Occup Environ Health; 2023 Jul; 96(5):675-683. PubMed ID: 36877242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring Surface Contamination by Antineoplastic Drugs in Italian Hospitals: Performance-Based Hygienic Guidance Values (HGVs) Project.
    Sottani C; Grignani E; Oddone E; Dezza B; Negri S; Villani S; Cottica D
    Ann Work Expo Health; 2017 Oct; 61(8):994-1002. PubMed ID: 29028251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter evaluation of a new closed system drug-transfer device in reducing surface contamination by antineoplastic hazardous drugs.
    Bartel SB; Tyler TG; Power LA
    Am J Health Syst Pharm; 2018 Feb; 75(4):199-211. PubMed ID: 29339374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter study of environmental contamination with cyclophosphamide, ifosfamide, and methotrexate in 66 Canadian hospitals: A 2016 follow-up study.
    Roland C; Caron N; Bussières JF
    J Occup Environ Hyg; 2017 Aug; 14(8):661-669. PubMed ID: 28574754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occupational exposure to antineoplastic drugs in hospital environments: potential risk associated with contact with cyclophosphamide- and ifosfamide-contaminated surfaces.
    Mucci N; Dugheri S; Farioli A; Garzaro G; Rapisarda V; Campagna M; Bonari A; Arcangeli G
    Med Pr; 2020 Sep; 71(5):519-529. PubMed ID: 32667290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous determination of gemcitabine, taxol, cyclophosphamide and ifosfamide in wipe samples by high-performance liquid chromatography/tandem mass spectrometry: protocol of validation and uncertainty of measurement.
    Sottani C; Turci R; Schierl R; Gaggeri R; Barbieri A; Violante FS; Minoia C
    Rapid Commun Mass Spectrom; 2007; 21(7):1289-96. PubMed ID: 17340557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of a decontamination procedure in a pharmacy buffer room contaminated by 5 antineoplastic agents.
    Arpino P; Yeomelakis J; Oommen A
    Am J Health Syst Pharm; 2020 Dec; 77(24):2081-2088. PubMed ID: 33150407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surface wipe sampling for antineoplastic (chemotherapy) and other hazardous drug residue in healthcare settings: Methodology and recommendations.
    Connor TH; Zock MD; Snow AH
    J Occup Environ Hyg; 2016 Sep; 13(9):658-67. PubMed ID: 27019141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antineoplastic drugs contamination of workplace surfaces in two Portuguese hospitals.
    Viegas S; Pádua M; Veiga AC; Carolino E; Gomes M
    Environ Monit Assess; 2014 Nov; 186(11):7807-18. PubMed ID: 25096642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occupational exposure to antineoplastic drugs: what about hospital sanitation personnel?
    Labrèche F; Ouellet C; Roberge B; Caron NJ; Yennek A; Bussières JF
    Int Arch Occup Environ Health; 2021 Nov; 94(8):1877-1888. PubMed ID: 34410477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-sectional evaluation of surface contamination with 9 antineoplastic drugs in 93 Canadian healthcare centers: 2019 results.
    Palamini M; Gagné S; Caron N; Bussières JF
    J Oncol Pharm Pract; 2020 Dec; 26(8):1921-1930. PubMed ID: 32114883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.